DE3688721D1 - Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren. - Google Patents

Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.

Info

Publication number
DE3688721D1
DE3688721D1 DE8686105954T DE3688721T DE3688721D1 DE 3688721 D1 DE3688721 D1 DE 3688721D1 DE 8686105954 T DE8686105954 T DE 8686105954T DE 3688721 T DE3688721 T DE 3688721T DE 3688721 D1 DE3688721 D1 DE 3688721D1
Authority
DE
Germany
Prior art keywords
treatment
tumors
discovery
porphyrine derivatives
porphyrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686105954T
Other languages
English (en)
Other versions
DE3688721T2 (de
Inventor
Jerry C Bommer
Bruce F Burnham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of DE3688721D1 publication Critical patent/DE3688721D1/de
Application granted granted Critical
Publication of DE3688721T2 publication Critical patent/DE3688721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE86105954T 1985-04-30 1986-04-30 Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren. Expired - Lifetime DE3688721T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72878685A 1985-04-30 1985-04-30

Publications (2)

Publication Number Publication Date
DE3688721D1 true DE3688721D1 (de) 1993-08-26
DE3688721T2 DE3688721T2 (de) 1993-12-16

Family

ID=24928279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE86105954T Expired - Lifetime DE3688721T2 (de) 1985-04-30 1986-04-30 Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren.

Country Status (8)

Country Link
EP (1) EP0210351B1 (de)
JP (1) JPH0764728B2 (de)
AT (1) ATE91625T1 (de)
AU (1) AU589957B2 (de)
CA (1) CA1291710C (de)
DE (1) DE3688721T2 (de)
DK (1) DK168690B1 (de)
NO (1) NO173319C (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
JPS63192718A (ja) * 1987-02-06 1988-08-10 Hamari Yakuhin Kogyo Kk 肝障害抑制剤
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
CA2189528A1 (en) * 1994-05-13 1995-11-23 Michael Keith Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
AU2085302A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
HU230334B1 (hu) 2000-11-29 2016-02-29 Pci Biotech As Vírus közreműködésével történő, a citoszolba irányuló molekulabevitelre szolgáló fotokémiai internalizáció és eljárás
JP2011518891A (ja) * 2009-04-29 2011-06-30 ドイアテクフ コリア シーオー．，エルティーディー． クロリンｅ６−葉酸結合化合物およびキトサンを含有する癌治療用薬学的組成物
RU2537759C1 (ru) * 2013-07-12 2015-01-10 Евгений Валерьевич Жаров Способ фотодинамической терапии онкологических заболеваний
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
RU2604388C2 (ru) * 2015-04-29 2016-12-10 Евгений Владимирович Давыдов Флуоресцентная диагностика злокачественного новообразования животного

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819644B2 (ja) 1975-03-13 1983-04-19 ウェルファイド株式会社 スイチユウボウオザイ
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS57185220A (en) * 1981-05-07 1982-11-15 Yakult Honsha Co Ltd Carcinostatic agent containing chlorophyll derivative as active component
JPS58981A (ja) * 1981-06-26 1983-01-06 Tama Seikagaku Kk 水溶性ポルフイリン誘導体
EP0087441A1 (de) 1981-09-08 1983-09-07 Quentron Optics Pty. Ltd. Photostrahlungsverfahren und anordnung
AU581840B2 (en) * 1982-09-27 1989-03-09 Health Research Inc. Porphyrin derivatives
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
EP0210351A2 (de) 1987-02-04
AU5689186A (en) 1986-11-06
NO173319B (no) 1993-08-23
DK197286D0 (da) 1986-04-30
EP0210351A3 (en) 1990-09-05
EP0210351B1 (de) 1993-07-21
AU589957B2 (en) 1989-10-26
DE3688721T2 (de) 1993-12-16
DK168690B1 (da) 1994-05-24
DK197286A (da) 1987-01-23
JPS625912A (ja) 1987-01-12
CA1291710C (en) 1991-11-05
JPH0764728B2 (ja) 1995-07-12
NO861724L (no) 1986-10-31
NO173319C (no) 1993-12-01
ATE91625T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
DE3688721D1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
DE3650772D1 (de) Derivate von Indazole-3-carboxamide und -3-carboxylsäure
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
NO169014C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
NO863373L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO169171C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycero-3(2)-fosfo-l-serinderivater
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
SE8801907D0 (sv) Novel pharmacological compounds
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
DE3778873D1 (de) Derivate von vorstufen von carboxylsaeure-medikamenten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition